UBS Group
AGN

UBS Group’s Allergan plc AGN Stock Holding History

UBS Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,853,356
Closed -$1.21B – 8714
2020
Q1 		$1.21B Buy
6,853,356
+429,597
+7% +$80.9M 0.57% 29
2019
Q4 		$1.23B Buy
6,423,759
+755,331
+13% +$136M 0.43% 41
2019
Q3 		$954M Sell
5,668,428
-1,472,121
-21% -$240M 0.37% 56
2019
Q2 		$1.2B Buy
7,140,549
+5,506,943
+337% +$763M 0.46% 44
2019
Q1 		$239M Buy
1,633,606
+715,209
+78% +$104M 0.1% 200
2018
Q4 		$123M Sell
918,397
-275,486
-23% -$45.2M 0.06% 321
2018
Q3 		$227M Sell
1,193,883
-305,176
-20% -$56.1M 0.09% 221
2018
Q2 		$250M Sell
1,499,059
-168,401
-10% -$27M 0.11% 200
2018
Q1 		$281M Buy
1,667,460
+468,124
+39% +$78.5M 0.12% 190
2017
Q4 		$196M Buy
1,199,336
+40,747
+4% +$7.31M 0.08% 251
2017
Q3 		$237M Sell
1,158,589
-123,304
-10% -$28.7M 0.11% 197
2017
Q2 		$312M Buy
1,281,893
+138,305
+12% +$32.5M 0.16% 158
2017
Q1 		$273M Sell
1,143,588
-81,244
-7% -$18.9M 0.15% 168
2016
Q4 		$257M Buy
1,224,832
+3,148
+0.3% +$652K 0.14% 164
2016
Q3 		$281M Sell
1,221,684
-74,962
-6% -$18.3M 0.17% 145
2016
Q2 		$300M Buy
1,296,646
+172,869
+15% +$39.9M 0.19% 123
2016
Q1 		$301M Sell
1,123,777
-7,613
-0.7% -$2.18M 0.2% 115
2015
Q4 		$354M Sell
1,131,390
-408,899
-27% -$122M 0.23% 93
2015
Q3 		$419M Sell
1,540,289
-58,305
-4% -$17.9M 0.3% 60
2015
Q2 		$485M Sell
1,598,594
-31,939
-2% -$9.53M 0.32% 51
2015
Q1 		$485M Buy
1,630,533
+631,134
+63% +$180M 0.34% 52
2014
Q4 		$257M Buy
+999,399
New +$250M 0.18% 132

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

UBS Group's AGN Position: Q2 2020 in Review

UBS Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,853,356 shares — an estimated $1.21B sold.

UBS Group first reported a position in AGN in Q4 2014 and held it in 22 quarters. The position peaked at $1.23B in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • UBS Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • UBS Group sold 6,853,356 Allergan plc shares in Q2 2020, an estimated $1.21B.
  • UBS Group first reported a position in Allergan plc in Q4 2014 and held it in 22 quarters.
  • UBS Group's Allergan plc position peaked at $1.23B in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.